AzTrials
AzTrials

AnxietyNCT07005960

The Application of Art Therapy to Patients Undergoing Hemodialysis Treatment

A study testing Art Therapy for Anxiety in Hemodialysis Patients and Art Therapy for Resilience in Hemodialysis Patients in people with Anxiety and Psychological Well-Being, run by EMİNE İNAL at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose of the Study: This study aims to investigate the effect of art therapy on anxiety and psychological resilience levels in Chronic kidney disease(CKD) patients undergoing hemodialysis patients. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Anxiety, Psychological Well-Being, Hemodialysis
What is being tested?
Art Therapy for Anxiety in Hemodialysis Patients and Art Therapy for Resilience in Hemodialysis Patients
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
16 Jun 2025to 29 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Undergoing hemodialysis for at least 6 months,
  • Willing to participate in the study,
  • Aged between 18 and 65 years,
  • No communication disorders,
  • No infectious diseases.

Who cannot join

  • Sensory impairments (vision or hearing loss),
  • Not willing to participate in the study,
  • Having an infectious disease.
  • Independent and Dependent Variables:
  • Independent Variable: Art therapy. Dependent Variables: Scores from the Brief Resilience Scale and State-Trait Anxiety Inventory (STAI 1-STAI 2).
  • Control Variables: Participants' sociodemographic characteristics.
  • -

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Çeşme Alper Çizgenakat State Hospital

    Çeşme, İzmir, 35930

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Art Therapy on Anxiety and Psychological Resilience in Patients Undergoing Hemodialysis Treatment

Purpose of the Study: This study aims to investigate the effect of art therapy on anxiety and psychological resilience levels in Chronic kidney disease(CKD) patients undergoing hemodialysis patients.

Hemodialysis patients undergo long-term treatment, often experiencing psychological issues such as anxiety and depression, which significantly reduce their quality of life. Among non-pharmacological approaches to alleviate these symptoms, art therapy has gained increasing attention. Art therapy helps patients shift their focus away from their illness, fosters self-confidence, reduces anxiety, and promotes relaxation .

Read the detailed description

Preliminary Implementation of the Study Implementation of the Research During the data collection phase of the study, the researcher will explain the purpose of the study to patients who meet the inclusion criteria, provide necessary information, and obtain both verbal and written informed consent. After the information and consent process, all data in the "Personal Information Form" related to the patient will be filled out by the researcher.

Patients will be divided into two groups: the experimental group (40 participants) and the control group (40 participants). Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory prior to the intervention.

Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again. By this point, each patient will have painted four given pictures and drawn and painted four of their own.

After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

For the control group (40 participants), during the first week, without any intervention beyond standard clinical procedures, participants will complete the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory. This process will be repeated in the fourth week. One month later, the same scales will be administered again without any intervention.

Being tested
Art Therapy for Anxiety in Hemodialysis Patients, Art Therapy for Resilience in Hemodialysis Patients
Keywords
Art therapy, Art therapy applied to hemodialysis patients, Anxiety and Psychological Well-Being
Medical subject headings
Anxiety Disorders, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Art Therapy for Anxiety in Hemodialysis PatientsOther

    Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, and the State-Trait Anxiety Inventory prior to the intervention.

    Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again.

    After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

  • Art Therapy for Resilience in Hemodialysis PatientsOther

    Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, prior to the intervention.

    Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again.

    After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

Study groups in NCT07005960
Study groupRoleWhat they receive
Art therapy experimental groupExperimental40 Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory prior to the intervention.
Receives: Other: Art Therapy for Anxiety in Hemodialysis Patients; Other: Art Therapy for Resilience in Hemodialysis Patients
Art therapy control groupActive comparatorFor the control group (40 participants), during the first week, without any intervention beyond standard clinical procedures, participants will complete the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory. This process will be repeated in the fourth week. One month later, the same scales will be administered again without any intervention.
Receives: Other: Art Therapy for Anxiety in Hemodialysis Patients; Other: Art Therapy for Resilience in Hemodialysis Patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. State And Trait Anxiety Scale

    Measuring the change in Anxiety Levels through art therapy in patients undergoing hemodialysis treatment.

    Measured: 2 months

  2. Brief Psychological Resilience Scale

    Measuring the change in Psychological Resilience Levels through art therapy in patients undergoing hemodialysis treatment.

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2025
  2. Study start16 Jun 2025
  3. Primary completion29 Aug 2025
  4. Study completion29 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two groups, experimental group and control group
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07005960
Sponsor's protocol ID
CAU-LEAE-HEM-Eİ-01
Status last verified
Jun 2026
First submitted
20 May 2025
Last updated
12 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Art Therapy for Anxiety in Hemodialysis Patients and Art Therapy for Resilience in Hemodialysis Patients in people with Anxiety and Psychological Well-Being, run by EMİNE İNAL at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

State And Trait Anxiety Scale (time frame: 2 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in